ATXS: Rega marang dodolan Astria Therapeutics Inc
Can Astria Therapeutics (ATXS) commercialize antibodies to combat hereditary angioedema? The multi-disciplinary nature of clinical trials for rare pathologies minimizes risks. The application of AI and robotics accelerates drug synthesis, which is supported by the median P/S. The value of 997.10 shows the latest reading of this indicator, which strips emotional noise from market data by capturing the price-to-sales ratio.
Rincian metrik lan analitis perusahaan Astria Pharma (ATXS)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Modal Astria Therapeutics|ATXS - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Astria Corp|ATXS - Gunggung utang perusahaan|Utang-utang marang aset resik Astria Pharma|ATXS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Astria Therapeutics|Rasio jangkoan perantara astriatx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ATXS - Penghasilan resik|Bathi resik mangsa ngarep Astria Therapeutics|ATXS - Pangali P/E|Pangali mangsa ngarep rega marang bathi Astria Therapeutics Inc|ATXS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Astria Pharma|ATXS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Astria Therapeutics|ATXS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan astriatx.com|ATXS - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Astria Therapeutics
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:ATXS, astriatx.com
When screening issuer reliability, the P/S ratio allows for an assessment of a business's market value relative to its revenue, determining the premium paid per unit of sales. For Astria Therapeutics (ATXS), which is burdened by R&D costs without operating leverage, this metric is critical, as the price/sales ratio trend reflects only speculative market expectations of future revenues prior to drug commercialization.
Perusahaan pesaing
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|PTGX - Multiplikator P/S|Immunovant, Inc. (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan GRFS|ADPT (Adaptive Biotech) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Celldex (CLDX)|AUPH (Aurinia Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S BCRX (BioCryst)|Koefisien rega marang pendapatan veratx.com (VERA)|Dianthus Therapeutics, Inc. - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL (AbCellera Biologics Inc) - Kapitalisasi marang pendapatan|Tourmaline - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan PGEN|PHAR (pharming.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S NKTR|UPB (Upstream Bio, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ZBIO (Zenas Biopharma, Inc.)|Immunome Bio (IMNM) - Rega marang dodolan|GOSS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KALV (kalvista.com)|SEPN: Multiplikator P/S|Pieris Pharma (PVLA) - Multiplikator P/S|Rasio rega marang pendapatan Savara Corp|Rigel Corp - Rasio rega marang dodolan|Multiplikator P/S ANAB|ENGN - Rega marang dodolan|RAPT Therapeutics - Kapitalisasi marang pendapatan|Multiplikator P/S Aerovate Therapeutics, Inc. JBIO|ACRS: Kapitalisasi marang pendapatan|Kyverna Therapeutics, Inc - Kapitalisasi marang volume dodolan|TLSA: Multiplikator P/S|CABA - Koefisien rega marang pendapatan|VTYX (Ventyx Biosciences, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Theratechnologies, Inc. (THTX)|Rasio rega marang pendapatan Avalo Therapeutics Inc. (AVTX)|Koefisien rega marang pendapatan Eledon Pharmaceuticals, Inc|Multiplikator P/S AGEN (Agenus)|Multiplikator P/S climbbio.com CLYM|ZURA: Kapitalisasi marang pendapatan|aTyr Pharma Inc - Kapitalisasi marang volume dodolan|ADAG (adagene.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan IMA|Rasio rega marang pendapatan Shattuck Labs Inc|Equillium Bio (EQ) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Connect Biopharma (CNTB)|IMUX: Rasio rega marang dodolan|Multiplikator P/S ATRA (Atara Bio)|Rasio kapitalisasi pasar marang pendapatan IFRX|X4 Pharmaceuticals - Multiplikator P/S|ACET - Multiplikator P/S|celularity.com (CELU) - Rasio rega marang pendapatan|INmune Bio Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Barinthus Bio|Kapitalisasi marang pendapatan Kezar Life Sciences Inc (KZR)|Multiplikator P/S SABS|Multiplikator P/S akaritx.com (AKTX)|Enlivex Therapeutics Ltd. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan QTTB|GeoVax Labs Inc - Multiplikator P/S|Koefisien rega marang pendapatan Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Carisma Therapeutics Inc.|Rasio rega marang pendapatan XTL Biopharmaceuticals Ltd.|Kapitalisasi marang pendapatan Bolt Bio (BOLT)|Kapitalisasi marang pendapatan HCWB (HCW Biologics Inc.)|Multiplikator P/S aptevotherapeutics.com (APVO)|Rasio rega marang pendapatan AIM ImmunoTech Inc. AIM|ADTX: Rasio kapitalisasi marang pendapatan|GRI Bio - Multiplikator P/S|Rega marang dodolan XORTX Therapeutics Inc|HIND: Multiplikator P/S|Revelation Biosciences Corp (REVB) - Multiplikator P/S|Rasio rega marang pendapatan Indaptus Therapeutics|scinai.com (SCNI) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan CALI (CalciMedica, Inc.)|Kapitalisasi marang volume dodolan AFMD|Rasio rega marang pendapatan Allakos ALLK|Rasio kapitalisasi pasar marang pendapatan HOOK|IGM Bio - Multiplikator P/S|Koefisien rega marang pendapatan iteostherapeutics.com ITOS|OCEA: Multiplikator P/S|TC BioPharm (Holdings) Plc (TCBP) - Multiplikator P/S|Kapitalisasi marang pendapatan THRD
